Menu Mobile
Aguarde Carregando

VII International Symposium on Translational Oncology

Imagem do Evento: VII International Symposium on Translational Oncology
✪ Local: Medical School - Facisb | Barretos, SP - Brazil
Por:
Escolha a categoria
Código do evento: 74

VII International Symposium on Translational Oncology
Categoria do evento

O Hospital de Câncer de Barretos (HCB) conta com um Instituto de Ensino e Pesquisa (IEP), que congrega o Centro de Pesquisa em Oncologia Molecular (CPOM), Unidade de Pesquisa Clínica (UPC) e a Pós-Graduação em Oncologia, que constituem os alicerces para o desenvolvimento da oncologia do futuro, a medicina de precisão, nesta instituição. O CPOM é um centro avançado de pesquisa em oncologia molecular baseado nos mais modernos centros de pesquisa do mundo, viabilizando o acesso a recursos tecnológicos e laboratórios de citogenética, genética molecular, biologia molecular e celular, com estrutura que permite o desenvolvimento de pesquisas em diversas áreas da oncologia molecular. Assim, com o intuito de continuar a sua missão que é a de formar, divulgar e disseminar entre pesquisadores, oncologistas, residentes, alunos de pós-graduação, e demais profissionais de Saúde sobre os principais temas oncológicos da atualidade, o Instituto de Ensino e Pesquisa do Hospital do Câncer de Barretos está organizando o VII Simpósio Internacional de Oncologia Translacional do Hospital de Câncer de Barretos. Este evento, organizado por pesquisadores e médicos oncologistas do próprio instituto visa promover a discussão e interação entre o público alvo e pesquisadores de reconhecimento nacional e internacional, que desenvolvem seus trabalhos em centros de excelência nas diversas áreas da oncologia, o que contribuirá para a consolidação e melhora da medicina translacional e pesquisa clínica em oncologia no âmbito nacional e internacional.

Program

09/13/2019 (Friday)

07:00 am – 07:30 am | Registration
07:30 am – 07:40 am | Opening and Welcome
Rui Manuel Reis, PhD (Barretos Cancer Hospital, Barretos, Brazil) Scientific Director

07:40 am – 09:40 am | Session 1
Hereditary Cancer and genetic risk factors

Discussion Leaders: Dirce Maria Carraro,PhD / Rui Manuel Reis, PhD

07:40 am – 08:10 am |  Genetic analyses of a demographically defined population reveals new ovarian cancer predisposing gene candidates
Speaker: Patricia Tonin, PhD (McGill University Health Centre, Montrela, Canada) 

08:10 am 08:40 am | Deciphering genetic susceptibility to lung cancer
Speaker: James McKay, PhD ( IARC, Lyon, France) 

08:40 am 09:10 am | The germline mutation landscape of Hereditary Breast Cancer in Brazil
Speaker: Edenir Inez Palmero, PhD (Barretos Cancer Hospital, Barretos, Brazil) 

09:10 am – 09:40 am | Discussion

09:40 am – 10:10 am | Coffee-break and visit to the posters.

10:10 am – 12:10 am | Session 2
Early detection and cancer screening

Discussion Leaders: Denise Peixoto Guimarães, MD, PhD / José Humberto T. G. Fregnani, MD,PhD 

10:10 am – 10:40 am |  The wide effect of microbiota on cancer
Speaker:
Christian Jobin, MD, PhD (University of Florida, Gainesville, Florida) 

10:40 am – 11:10 am | What tools do we have to eliminate cervical cancer?
Speaker:
Luisa Lina Villa, PhD ( Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil) 

11:10 am – 11:40 pm | Integration of molecular biology, molecular pathology and epidemiology: a new paradigm into the screening and surveillance of head and neck tumors
Speaker:
Ana Carolina de Carvalho Peters, PhD (Barretos Cancer Hospital, Barretos, Brazil) 

11:40 am – 12:10 pm |  Discussion

12:10 pm – 12:40 pm |  Technical lecture

12:40 pm – 2:10 pm | Lunch

2:10 pm – 2:55 pm | Oral presentation of Best Abstracts
Discussion Leader:

2:10 pm – 2:20 pm |

2:20 pm – 2:30 pm |

2:30 pm – 2:40 pm |

2:40 pm – 2:55 pm | Discussion

2:55 pm – 4:55 pm – Session 3
Environmental factors and Exposome in cancer development

Discussion Leaders: Henrique Silveira, PhD / Fabiana de Lima Vazquez, PhD

2:55 pm – 3:25 pm – Etiological factors influence differences and consequences in lipid bodies formation between obese and non-obese associated esophageal tumors.
Speaker: Luis Felipe Ribeiro Pinto, PhD (National Cancer Institute – INCA, Rio de Janeiro, Brazil) 

3:25 pm – 3:55 pmExploring interactions between the exposome and cancer through metabolomics – Application to cohort studies
Speaker: Augustin Scalbert, PhD (International Agency for Research on Cancer -IARC, Lyon, France) 

3:55 pm – 4:25 pmLong term exposure assessment to urban air pollution: an autopsy based study
Speaker: Paulo Hilário Nascimento Saldiva, MD, PhD (Universidade de São Paulo, Instituto de Estudos Avançados USP, São Paulo, Brazil) 

4:25 pm – 4:55 pm - Discussion

4:55 pm – 6:55 pm – Session 4
Molecular biomarkers in translational oncology

Discussion Leaders: Patricia Reis, PhD  / Márcia Maria C. Silveira, PhD

4:55 pm – 5:25 pm –  Clonal hematopoiesis and malignant clonal evolution
Speaker:
Rodrigo Calado, PhD ( (FMRP/USP, Ribeirão Preto, Brazil) 

5:25 pm – 5:55 pm – Alterations of DNA methylation as biomarkers in tumors from the upper aerodigestive tract
Speaker:
Sheila Coelho Soares Lima, PhD (National Cancer Institute – INCA, Rio de Janeiro, Brazil) 

5:55 pm – 6:25 pmThe Molecular Landscape of Brazilian Lung Cancer: Searching for Clinically Relevant Biomarkers
Speaker:
Letícia Ferro Leal, PhD (Barretos Cancer Hospital, Barretos, Brazil) 

6:25 pm – 6:55pm – Discussion

 

09/14/2019 (Saturday)

 

07:30 am – 09:30 am – Session 5
Personalized Medicine

Discussion Leaders: Vinícius de Lima Vazquez, MD, PhD / Jeremy Andrew Squire, PhD 

07:30 am – 08:00 am – talk: t.b.a.
Speaker: talk: t.b.a.

08:00 am – 08:30 amThe Brazilian Initiative on Precision Medicine (BIPMed): contributions of the past four years
Speaker:
Iscia Lopes Centes, PhD ( UNICAMP, Campinas, Brazil) 

08:30 am – 09:00 am –  talk: t.b.a.
Speaker: Vivaldo Moura Neto, PhD (Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil)

09:00 am – 09:30 am – Discussion

09:30 am – 10:00 am – Coffee-break and visit of the posters.

10:00 am – 12:00 pm – Session 6
Innovative approaches for cancer discovery and treatment

Discussion Leaders: Osvaldo Novais de Oliveira Jr, PhD / Matias Eliseo Melendez, PhD

10:00 am – 10:30 am Oncolytic herpes simplex virus for cancer therapy
Speaker: 
Samuel D. Rabkin, PhD (Massachusetts General Hospital & Harvard Medical School, Boston, USA)

10:30 am – 11:00 am – The use of multi-omic data integration to reveal potential targets in HPV-related cancers
Speaker:
Marcelo Alves Soares, PhD (National Cancer Institute – INCA, Rio de Janeiro, Brazil)

11:00 am – 11:30 amMechanism of action of combi-molecules rationally designed to block multiple adverse signalling pathways and reverse MGMT-mediated resistance: relevance to immuno-oncology
Speaker: Bertrand Jean Claude, PhD (University McGill, Montreal, Canada) 

11:30 am – 12:00 pm – Discussion

12:00 pm – 12:30 pm –  Technical lecture

12:30 pm – 02:00 pm – Lunch

02:00 pm – 04:00 pm – Session 7
Immunotherapy and tumor microenvironment

Discussion Leaders: Céline Marques Pinheiro, PhD / Flávio Cárcano, MD, PhD

02:00 pm – 02:30 pm –  Lactate and acidification represent metabolic checkpoints in the tumor environment
Speaker:
Marina Kreutz, PhD ( University Hospital Regensburg, Regensburg, Alemanha)

02:30 pm – 03:00 pm – Systemic and tissue immune networks to identify novel targets and therapy response markers in cancer
Speaker: Kenneth Gollob, PhD (AC Camargo Cancer Center, São Paulo, Brazil)

03:00 pm – 03:30 pm – talk: t.b.a.
Speaker: Alvaro Alencar, MD, PhD (University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida)

03:30 pm – 04:00 pm – Discussion

04:00 pm – 06:00 pm – Session 8
Experimental models in translacional oncology

Discussion Leaders: Carlos Alberto Scrideli, MD, PhD / Silvia Teixeira, PhD

04:00 pm –04:30 pm – Zika virus: from enemy  to ally
Speaker:
Mayana Zatz, PhD (University of São Paulo – São Paulo, Brazil) 

04:30 pm – 05:00 pm – Exploiting viruses for the treatment of brain tumors 
Speaker: Sean Edward Lawler, PhD (Brigham and Women's Hospital – Harvard Medical School - Boston, USA) 

05:00 pm – 05:30 pm – Immune cell therapies for cancer: future promises and challenges
Speaker:
Mohan Sobhana Nandhu, PhD (Takeda Pharmaceutical International Co, Cambridge, USA) 

05:30 pm – 06:00 pm – Discussion

06:00 pm – 06:10 pm – Awards of the best oral presentation and poster
Discussion Leader:

06:00 pm – 06:10 pm – Closing remarks

06:10 pm – 06:20 pm - Farewell Coffee

Committee

Executive and Scientific Committee

Ana Carolina Carvalho
Adriane Evangelista Feijó
Céline Marques Pinheiro
Denise Guimarães
Edenir Inez Palmero
Fabiana Vazquez
Henrique Cesar Santejo Silveira
Letícia Ferro Leal
Luis Fernando Lopes
Márcia Maria Chiquitelli Marques Silveira
Mariana Tomazini Pinto
Matias Melendez
Pedro de Marchi
Ricardo dos Reis
Rui Manuel Vieira Reis
Silvia Teixeira
Vinícius de Lima Vazquez
Vinicius Duval da Silva
Viviane Aline Saito

 

Organizing Committee

Bianca Cristina Pereira
Camila Argolo Muniz
Caio Fernando de Oliveira
Dorion Denardi
Joyce Silva Pinto

Registration Fees

Health professionals and PhD – R$ 350,00

Graduate students – R$ 250,00

Undergraduate students – R$ 150,00

Employees from Barretos Cancer Hospital - R$ 150,00

Cancellation deadline of  Inscription - seven days

Confirmed International and National Speakers

Augustin Scalbert, PhD
IARC – Lyon, France.

https://www.iarc.fr/staff_member/dr-augustin-scalbert/




Alvaro Alencar, MD
University of Miami Sylvester Comprehensive Cancer Center – Miami, Florida

https://umiamihealth.org/sylvester-comprehensive-cancer-center/research/faculty/alvaro-j-alencar-md


Bertrand Jean Claude, PhD
MC Gill University, Montreal – Canadá.

https://www.mcgill.ca/expmed/dr-bertrand-jean-claude


Christian Jobin, MD, PhD
University of Florida, Gainesville – Florida, USA.

https://gastroliver.medicine.ufl.edu/about-us/meet-the-team/christian-jobin-ph-d/


James Mckay, PhD
IARC – Lyon, France.

https://www.iarc.fr/staff_member/dr-james-mckay/


Mohan Sobhana Nandhu, MD, PhD
State University of New York Upstate Medical University – New York, USA

https://www.researchgate.net/profile/Mohan_Sobhana_Nandhu


Patricia Tonin, PhD
MC Gill University – Montreal, Canadá.

http://rimuhc.ca/-/patricia-tonin


Sean Edward Lawler, PhD
Brigham and Women's Hospital – Boston, USA

https://connects.catalyst.harvard.edu/Profiles/display/Person/78460


Marina Kreutz, PhD
University Hospital Regensburg - Regensburg, Alemanha
https://www.researchgate.net/profile/Marina_Kreutz2


Samuel D. Rablin
Massachusetts General Hospital & Harvard Medical School - Boston, USA

http://www.dfhcc.harvard.edu/insider/member-detail/member/samuel-d-rabkin-phd/


Ana Carolina de Carvalho Peters, PhD
Barretos Cancer Hospital - Barretos, Brazil
http://lattes.cnpq.br/0525201717724232


Céline Marques Pinheiro, PhD
Barretos Cancer Hospital - São Paulo, Brazil

http://lattes.cnpq.br/5324700292116152


Denise Peixoto Guimarães, MD, PhD
Barretos Cancer Hospital - São Paulo, Brazil

http://lattes.cnpq.br/8956917571336734




Dirce Maria Carraro, PhD
AC Camargo Cancer Center - São Paulo, Brazil
http://lattes.cnpq.br/7584415865388877


Edenir Inez Palmero, PhD
Barretos Cancer Hospital - Barretos, Brazil

http://lattes.cnpq.br/4094427750209083


Fabiana de Lima Vazquez, PhD
Barretos Cancer Hospital - São Paulo, Brazil

http://lattes.cnpq.br/2270697027685436


Flavio Cárcano, MD, PhD
Barretos Cancer Hospital - São Paulo, Brazil

http://lattes.cnpq.br/2337234820067393


Henrique César Santejo Silveira, PhD
Barretos Cancer Hospital - São Paulo, Brazil

http://lattes.cnpq.br/2655752232849220


Iscia Teresinha Lopes Cendes
UNICAMP - Campinas, Brazil

http://lattes.cnpq.br/3944020856408245


Jeremy Andrew Squire, MD, PhD
Faculdade de Medicina de Ribeirão Preto - USP - Ribeirão Preto, Brazil

http://lattes.cnpq.br/6790462418235210


José Humberto T. G. Fregnani, MD, PhD
A.C. Camargo Cancer Center - São Paulo, Brazil
http://lattes.cnpq.br/3572809987324115


Kenneth John Gollob , PhD
AC Camargo Cancer Center - São Paulo, Brazil

http://lattes.cnpq.br/4314074851986989


Letícia Ferro Leal, PhD
Barretos Cancer Hospital - Barretos, Brazil

http://lattes.cnpq.br/4142456089656080


Luis Felipe Ribeiro Pinto, PhD
National Cancer Institute – INCA - Rio de Janeiro, Brazil

http://lattes.cnpq.br/0774809439237135


Luisa Lina Villa, PhD
Instituto do Câncer do Estado de São Paulo - São Paulo, Brazil

http://lattes.cnpq.br/8379358682656422


Marcelo Alves Soares, PhD
National Cancer Institute – INCA - Rio de Janeiro, Brazil

http://lattes.cnpq.br/7635170597670838


Márcia Maria Chiquitelli Marques Silveira, PhD
Barretos Cancer Hospital - São Paulo, Brazil

http://lattes.cnpq.br/7852430432457471


Matias Eliseo Melendez, PhD
Barretos Cancer Hospital - São Paulo, Brazil

http://lattes.cnpq.br/2746759168721010


Mayana Zatz, PhD
Universidade de São Paulo – USP - São Paulo, Brazil

http://lattes.cnpq.br/2454447846752426


Osvaldo Novais de Oliveira Junior, PhD
Universidade de São Paulo, Instituto de Física de São Carlos – USP - São Carlos, Brazil

http://lattes.cnpq.br/8582867831317500


Patricia Pintor dos Reis, PhD
Universidade Estadual Paulista Júlio de Mesquita Filho – UNESP - Botucatu, Brazil

http://lattes.cnpq.br/1109525021631011


Paulo Hilário Nascimento Saldiva, MD, PhD
Universidade de São Paulo, Instituto de Estudos Avançados – USP - São Paulo, Brazil

http://lattes.cnpq.br/5450805572417395


Rodrigo do Tocantins Calado De Saloma Rodrigues, PhD
Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo – USP - Ribeirão Preto, Brazil

http://lattes.cnpq.br/5187902541390363


Rui Manuel Vieira Reis, PhD
Barretos Cancer Hospital - São Paulo, Brazil

http://lattes.cnpq.br/6448722653761487


Sheila Coelho Soares Lima, PhD
National Cancer Institute – INCA - Rio de Janeiro, Brazil

http://lattes.cnpq.br/7690812849140276


Silvia Teixeira, PhD
Barretos Cancer Hospital - São Paulo, Brazil

http://lattes.cnpq.br/7569020525796162


Vinícius de Lima Vazquez, MD, PhD
Barretos Cancer Hospital - São Paulo, Brazil

http://lattes.cnpq.br/7827758855739399

n\hbsss   

 

 

Submit Abstract

DEADLINE TO SUBMIT ABSTRACT: 04/20/2019 - 06/30/2019

FOR MORE INFORMATION: CLICK HERE

 

Sponsors | Support

SUPPORT

 

Todos direitos reservados © 1999 - 2019 Hospital de Câncer de Barretos.